STAT

APRIL 9, 2024

That’s big news for an industry that has been icy for the last three years, once the attention the Covid pandemic brought to drug companies began to fade. The numbers are in, and biotech startups recently closed out their best fundraising quarter in two years, signaling that the industry downturn may soon be a thing of the past.

141

141

STAT

DECEMBER 1, 2023

In Ukraine, a little bit of good news can go a long way, and the lifesaving work being done as a result of the President’s Emergency Plan for AIDS Relief (PEPFAR) has been a rare but reliable source of good news. That’s why the U.S. Read the rest…

144

144

STAT

JANUARY 30, 2024

NEW YORK — The U.S. syphilis epidemic isn’t abating, with the rate of infectious cases rising 9% in 2022, according to a new federal government report on sexually transmitted diseases in adults. But there’s some unexpected good news: The rate of new gonorrhea cases fell for the first time in a decade.

139

139

STAT

FEBRUARY 12, 2024

5, Buckingham Palace shared the news that King Charles had started treatment for cancer. ” Indeed, news of King Charles’ initial prostate procedure in January 2024 sparked an immediate and significant increase in traffic for the National Health Service prostate enlargement page. Read the rest…

115

115

STAT

APRIL 8, 2024

We have news for you from the annual meeting of the American Association for Cancer Research, and also from the annual meeting of the American College of Cardiology. We have news for you from the annual meeting of the American Association for Cancer Research, and also from the annual meeting of the American College of Cardiology.

105

105

pharmaphorum

MARCH 1, 2024

Stay up to date with the latest news in the life sciences industry with highlights from clinical trials involving CSL, Arcturus, Sanofi, Nexviazyme, and REGENXBIO from the week of 5th to 9th February 2024.

109

109

STAT

SEPTEMBER 27, 2023

It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this? Yet when T.J. ” He had a point.

FDA 144

FDA 144

STAT

MARCH 12, 2024

The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient community hard. Read the rest…

134

134

pharmaphorum

FEBRUARY 6, 2024

Stay updated with the latest news on hiring trends in the pharmaceutical and biotech industries. Learn about the companies and professionals making waves in the field from January 2024 in a new instalment of Changing Faces.

110

110

STAT

APRIL 1, 2024

And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.  Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

137

137

STAT

FEBRUARY 28, 2024

Elisabeth Bik, a microbiologist by training, has become one of the world’s most influential science detectives. Bik first became interested in plagiarism as a hobby while working as a researcher at Stanford University in 2013. Read the rest…

143

143

Fierce Healthcare

APRIL 17, 2024

Below is a roundup of payer-centric news for the week of April 15, 2024. This week, Elevance Health acquires its competitor in New York, a Virginia health plan is under investigation and the OIG office looks into vertical consolidation.

74

74

STAT

APRIL 3, 2024

Today we talk about how biopharma plans to harness AI for clinical trial design, why two experts think Medicare ought to cover the costly GLP-1 drugs, and what news from Roivant means for its business strategy. Want to stay on top of the science and politics driving biotech today?  Read the rest…

101

101

PharmExec

APRIL 26, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmExec

APRIL 26, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmExec

APRIL 26, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmExec

APRIL 26, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

STAT

APRIL 1, 2024

Major news organizations and even state governments have pinned social media apps as addictive , dangerous, and the cause of the youth mental health crisis. Since the U.S. surgeon general’s 2023 advisory on social media and teen mental health, public concern has skyrocketed around adolescents’ digital lives.

145

145

STAT

JANUARY 22, 2024

The news comes as the famed cancer research and treatment center is now reviewing scores of studies co-authored by some of its leading researchers, including CEO Laurie Glimcher, COO William Hahn, and prominent scientists Irene Ghobrial and Kenneth Anderson. Read the rest…

Hospitals 144

Hospitals 144

Outsourcing Pharma

APRIL 4, 2024

In an overwhelming response to the news that SimBioSys and General Inception had joined forces to use advanced AI and biophysical modeling, to gain deeper insights into tumor biology, the industry has spoken.

80

80

STAT

APRIL 2, 2024

The news represents a setback for an ambitious project to not only bring forward one of the first gene-editing treatments in humans, but to also do so not for a rare condition but for the leading killer in the developed world. Continue to STAT+ to read the full story…

Compounding 119

Compounding 119

STAT

MARCH 28, 2024

Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for? Read the rest…

FDA 112

FDA 112

PharmExec

APRIL 25, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

PharmExec

APRIL 25, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmExec

APRIL 25, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmExec

APRIL 25, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

STAT

FEBRUARY 1, 2023

A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that disruptive innovation in science has dramatically and mysteriously declined 90% since 1945. The study has prompted a wave of news coverage and tweets decrying the apparent languishing of modern science. Read the rest…

145

145

STAT

MARCH 21, 2024

In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday that, for the first time, it had transplanted a kidney from a CRISPR gene-edited pig into a living patient. Surgeons performed the milestone procedure over four hours on Saturday, March 16, without complications.

Hospitals 145

Hospitals 145

STAT

JANUARY 11, 2024

The Pashai family of Dallas on Thursday got some good news, but not exactly the news they had spent the last month praying for. “It opens the door, but at this point they’re giving only the bare minimum.” ” Read the rest…

107

107

STAT

MARCH 21, 2024

Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular? Read the rest…

FDA 103

FDA 103

STAT

FEBRUARY 26, 2024

Damian here with a look at some renewed interest in a yesteryear biotech craze, news of an FDA flex, and a dive into the science of vaccinology. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Read the rest…

FDA 100

FDA Vaccines 100

pharmaphorum

NOVEMBER 7, 2023

Frontiers Health 23 - Day 1 from the marvellous Auditorium della Tecnica in Rome, where we are set to bring you the biggest news stories, trends, and industry insights

121

121

PharmExec

APRIL 24, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

PharmExec

APRIL 24, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

PharmExec

APRIL 24, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

STAT

APRIL 1, 2024

News of the proposed deal broke last week, but neither of the two famously secretive companies would share details on the plan, including the purchase price. Most of them share a common trait: They’re independent groups, not affiliated with hospital chains. Continue to STAT+ to read the full story…

Hospitals 131

Hospitals Insurance 131

STAT

OCTOBER 11, 2023

8 and then take over as CEO in the “latter half of 2024,” the company said in a news release. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release. Humana’s stock fell by more than 2% on the news Wednesday morning.

Insurance 112

Insurance 112